The S-4 filing is a procedural step confirming the exchange offer is on track. With Medtronic fully exiting, MMED's free float will increase dramatically, likely improving liquidity and index eligibility. Monitor the exchange offer period and any MDT shareholder participation rates; a successful completion removes overhang and could drive re-rating as a pure-play diabetes device company.
Price Chart
Executive Summary
MiniMed filed an S-4 registration statement for Medtronic's exchange offer, where Medtronic shareholders can swap MDT shares for up to 225.4M MMED shares (80.1% of outstanding). Medtronic currently owns 89.86% of MiniMed and will fully exit its stake if the offer is completed, leaving MiniMed as a fully independent public company. This is a procedural step advancing the separation timeline, with no changes to deal terms or new financial projections disclosed.
Key Financial Metrics
Key Facts
- Medtronic offers to exchange up to 225,361,295 MMED shares (80.1% of outstanding) for MDT ordinary shares.
- Medtronic currently owns ~89.86% of MiniMed; full exit if oversubscribed (additional 27,452,053 shares).
- MiniMed filed Form S-4 registration statement on September 14, 2026, a key procedural milestone.
- CEO Que Dallara emphasizes complete autonomy over capital allocation, product roadmap, and speed post-separation.
- No changes to deal terms, no updated financials, and no opposition or regulatory hurdles mentioned.
Financial Impact
Medtronic exiting an ~89.86% stake in a $6.3B market cap company; implied value of exchanged shares ~$5.1B based on current market cap. No premium or deal value disclosed.
Risk Factors
- Exchange offer may be undersubscribed, leaving Medtronic with a residual stake.
- No guarantee of timing or regulatory clearance for the separation.
- Post-separation execution risk as an independent company with no Medtronic support.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001628280-26-061673 |
| Document: 0001628280-26-061673-index-headers.html | 0001628280-26-061673 |
| Document: 0001628280-26-061673-index.html | 0001628280-26-061673 |
| Document: 0001628280-26-061673.txt | 0001628280-26-061673 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 14, 2026 18d ago | S-4 / 425 | $21.97 $21.12 | ▼ −3.87% | ▼ −3.98% | $19.56 (−10.97%) |
Sep 1, 2026 4w ago | 8-K | $22.42 $22.76 | ▲ +1.52% | ▲ +1.44% | $19.56 (−12.76%) |
Jul 6, 2026 12w ago | 3 | $15.37 $15.04 | ▼ −2.15% | ▼ −2.70% | $19.56 (+27.26%) |
Jun 29, 2026 13w ago | 8-K | $14.88 $15.29 | ▲ +2.76% | ▲ +1.37% | $19.56 (+31.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access